What Researchers Did
Researchers retrospectively analyzed outcomes of hyperbaric oxygen treatment (HBOT) in 50 breasts with mastectomy flap ischemia to evaluate its effectiveness in a case series.
What They Found
Hyperbaric oxygen treatment (HBOT) was initiated a median of 3 days post-surgery for a median of 12 sessions. The breast skin surface area scores improved in 34% of observations, and 29 breasts (58%) recovered without additional surgery. Pre-operative radiotherapy (OR 7.2) and postoperative infection (OR 15.4) were identified as significant risk factors for re-operation.
What This Means for Canadian Patients
For Canadian patients experiencing mastectomy flap ischemia, hyperbaric oxygen treatment may offer a non-surgical option to potentially improve flap recovery and reduce the need for further operations. Patients should discuss this treatment with their healthcare providers to understand its potential benefits and risks in their specific situation.
Canadian Relevance
This study does not have a direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A key limitation of this study is its retrospective case series design, which limits the ability to establish causality and control for confounding factors.